OpenURL Connection Search

Select item for more details and to access through your institution.

Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes.
Published in:
Renal Failure, 2019, v. 41, n. 1, p. 427, doi. 10.1080/0886022X.2019.1614057
By:
- Sekercioglu, Nigar;
- Lovblom, Leif Erik;
- Bjornstad, Petter;
- Lovshin, Julie A.;
- Lytvyn, Yuliya;
- Boulet, Geneviève;
- Farooqi, Mohammed A.;
- Orszag, Andrej;
- Lai, Vesta;
- Tse, Josephine;
- Cham, Leslie;
- Keenan, Hillary A.;
- Brent, Michael H.;
- Paul, Narinder;
- Bril, Vera;
- Perkins, Bruce A.;
- Cherney, David Z. I.
Publication type:
Article
Management of Type 2 Diabetic Kidney Disease in 2022: A Narrative Review for Specialists and Primary Care.
Published in:
Canadian Journal of Kidney Health & Disease, 2023, p. 1, doi. 10.1177/20543581221150556
By:
- Cherney, David Z. I.;
- Bell, Alan;
- Girard, Louis;
- McFarlane, Philip;
- Moist, Louise;
- Nessim, Sharon J.;
- Soroka, Steven;
- Stafford, Sara;
- Steele, Andrew;
- Tangri, Navdeep;
- Weinstein, Jordan
Publication type:
Article
Management of Type 2 Diabetic Kidney Disease in 2022: A Narrative Review for Specialists and Primary Care.
Published in:
Canadian Journal of Kidney Health & Disease, 2023, v. 10, p. 1, doi. 10.1177/20543581221150556
By:
- Cherney, David Z. I.;
- Bell, Alan;
- Girard, Louis;
- McFarlane, Philip;
- Moist, Louise;
- Nessim, Sharon J.;
- Soroka, Steven;
- Stafford, Sara;
- Steele, Andrew;
- Tangri, Navdeep;
- Weinstein, Jordan
Publication type:
Article
Kidney outcomes using a sustained ≥40% decline in eGFR: A meta‐analysis of SGLT2 inhibitor trials.
Published in:
Clinical Cardiology, 2021, v. 44, n. 8, p. 1139, doi. 10.1002/clc.23665
By:
- Cherney, David Z. I.;
- Dagogo‐Jack, Samuel;
- McGuire, Darren K.;
- Cosentino, Francesco;
- Pratley, Richard;
- Shih, Weichung J.;
- Frederich, Robert;
- Maldonado, Mario;
- Liu, Jie;
- Wang, Shuai;
- Cannon, Christopher P.
Publication type:
Article
The New Biology of Diabetic Kidney Disease—Mechanisms and Therapeutic Implications.
Published in:
Endocrine Reviews, 2020, v. 41, n. 2, p. 202, doi. 10.1210/endrev/bnz010
By:
- Lytvyn, Yuliya;
- Bjornstad, Petter;
- Raalte, Daniel H van;
- Heerspink, Hiddo L;
- Cherney, David Z I
Publication type:
Article
Renal and Vascular Effects of Uric Acid Lowering in Normouricemic Patients With Uncomplicated Type 1 Diabetes.
Published in:
2017
By:
- Lytvyn, Yuliya;
- Har, Ronnie;
- Locke, Amy;
- Lai, Vesta;
- Fong, Derek;
- Advani, Andrew;
- Perkins, Bruce A.;
- Cherney, David Z. I.
Publication type:
journal article
The Effect of Cyclooxygenase-2 Inhibition on Renal Hemodynamic Function in Humans With Type 1 Diabetes.
Published in:
Diabetes, 2008, v. 57, n. 3, p. 688, doi. 10.2337/db07-1230
By:
- Cherney, David Z. I.;
- Miller, Judith A.;
- Scholey, James W.;
- Bradley, Timothy J.;
- Slorach, Cameron;
- Curtis, Jaqueline R.;
- Dekker, Maria G.;
- Nasrallah, Rania;
- Hébert, Richard L.;
- Sochett, Etienne B.
Publication type:
Article
Gender, clamped hyperglycemia and arterial stiffness in patients with uncomplicated type 1 diabetes mellitus.
Published in:
Clinical & Experimental Hypertension, 2014, v. 36, n. 3, p. 187, doi. 10.3109/10641963.2013.804543
By:
- Cherney, David Z. I.;
- Montanari, Alberto
Publication type:
Article
FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes.
Published in:
American Journal of Managed Care, 2021, v. 27, p. S375, doi. 10.37765/ajmc.2021.88808
By:
- Pochopień, Michał T.;
- Cherney, David Z. I.;
- Folkerts, Kerstin;
- Levy, Pierre;
- Millier, Aurélie;
- Morris, Stephen;
- Roy-Chaudhury, Prabir;
- Sullivan, Sean D.;
- Mernagh, Paul
Publication type:
Article
Potential Use of SGLT-2 Inhibitors in Obstructive Sleep Apnea: A new treatment on the horizon.
Published in:
Sleep & Breathing, 2023, v. 27, n. 1, p. 77, doi. 10.1007/s11325-022-02606-1
By:
- Tanriover, Cem;
- Ucku, Duygu;
- Akyol, Merve;
- Cevik, Enes;
- Kanbay, Asiye;
- Sridhar, Vikas S.;
- Cherney, David Z. I.;
- Kanbay, Mehmet
Publication type:
Article
Proximal versus distal diuretics in congestive heart failure.
Published in:
Nephrology Dialysis Transplantation, 2024, v. 39, n. 9, p. 1392, doi. 10.1093/ndt/gfae058
By:
- Nardone, Massimo;
- Sridhar, Vikas S;
- Yau, Kevin;
- Odutayo, Ayodele;
- Cherney, David Z I
Publication type:
Article
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics.
Published in:
Nephrology Dialysis Transplantation, 2020, v. 35, n. 10, p. 1700, doi. 10.1093/ndt/gfaa234
By:
- Wheeler, David C;
- Stefansson, Bergur V;
- Batiushin, Mikhail;
- Bilchenko, Oleksandr;
- Cherney, David Z I;
- Chertow, Glenn M;
- Douthat, Walter;
- Dwyer, Jamie P;
- Escudero, Elizabeth;
- Pecoits-Filho, Roberto;
- Furuland, Hans;
- Górriz, José Luis;
- Greene, Tom;
- Haller, Hermann;
- Hou, Fan Fan;
- Kang, Shin-Wook;
- Isidto, Rey;
- Khullar, Dinesh;
- Mark, Patrick B;
- McMurray, John J V
Publication type:
Article
The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial.
Published in:
Nephrology Dialysis Transplantation, 2020, v. 35, n. 5, p. 895, doi. 10.1093/ndt/gfz294
By:
- Opingari, Erika;
- Verma, Subodh;
- Connelly, Kim A;
- Mazer, Cyril David;
- Teoh, Hwee;
- Quan, Adrian;
- Zuo, Fei;
- Pan, Yi;
- Bhatt, Deepak L;
- Zinman, Bernard;
- Leiter, Lawrence A;
- Yan, Andrew T;
- Cherney, David Z I;
- Gilbert, Richard E
Publication type:
Article
Plasma biomarkers improve prediction of diabetic kidney disease in adults with type 1 diabetes over a 12-year follow-up: CACTI study.
Published in:
Nephrology Dialysis Transplantation, 2018, v. 33, n. 7, p. 1189, doi. 10.1093/ndt/gfx255
By:
- Bjornstad, Petter;
- Pyle, Laura;
- Cherney, David Z I;
- Johnson, Richard J;
- Sippl, Rachel;
- Wong, Randy;
- Rewers, Marian;
- Snell-Bergeon, Janet K
Publication type:
Article
SGLT2 Inhibition in Patients With Type 2 Diabetes Mellitus Post-Nephrectomy: A Single-Center Case Series.
Published in:
Canadian Journal of Kidney Health & Disease, 2021, p. 1, doi. 10.1177/20543581211065528
By:
- Škrtić, Marko;
- Cherney, David Z. I.;
- Sridhar, Vikas S.;
- Chan, Christopher T. M.;
- Kitchlu, Abhijat
Publication type:
Article
SGLT2 Inhibition in Patients With Type 2 Diabetes Mellitus Post-Nephrectomy: A Single-Center Case Series.
Published in:
Canadian Journal of Kidney Health & Disease, 2021, p. 1, doi. 10.1177/20543581211065528
By:
- Škrtić, Marko;
- Cherney, David Z. I.;
- Sridhar, Vikas S.;
- Chan, Christopher T. M.;
- Kitchlu, Abhijat
Publication type:
Article
Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes.
Published in:
PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0141085
By:
- Perkins, Bruce A.;
- Cherney, David Z. I.;
- Soleymanlou, Nima;
- Lee, Justin A.;
- Partridge, Helen;
- Tschirhart, Holly;
- Zinman, Bernard;
- Mazze, Roger;
- Fagan, Nora;
- Kaspers, Stefan;
- Woerle, Hans-Juergen;
- Broedl, Uli C.;
- Johansen, Odd Erik
Publication type:
Article
The Urinary Cytokine/Chemokine Signature of Renal Hyperfiltration in Adolescents with Type 1 Diabetes.
Published in:
PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0111131
By:
- Har, Ron L. H.;
- Reich, Heather N.;
- Scholey, James W.;
- Daneman, Denis;
- Dunger, David B.;
- Moineddin, Rahim;
- Dalton, R. Neil;
- Motran, Laura;
- Elia, Yesmino;
- Deda, Livia;
- Ostrovsky, Masha;
- Sochett, Etienne B.;
- Mahmud, Farid H.;
- Cherney, David Z. I.
Publication type:
Article
Renal Hyperfiltration and Systemic Blood Pressure in Patients with Uncomplicated Type 1 Diabetes Mellitus.
Published in:
PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0068908
By:
- Yang, Gary K.;
- Maahs, David M.;
- Perkins, Bruce A.;
- Cherney, David Z. I.
Publication type:
Article
Mycophenolate mofetil causing deep venous thrombosis in a renal transplant patient with factor V Leiden.
Published in:
Nephrology Dialysis Transplantation, 2001, v. 16, n. 8, p. 1702, doi. 10.1093/ndt/16.8.1702
By:
- Cherney, David Z. I.;
- Zaltzman, Jeffrey S.
Publication type:
Article
SGLT2 Inhibition in Type 1 Diabetes with Diabetic Kidney Disease: Potential Cardiorenal Benefits Can Outweigh Preventable Risk of Diabetic Ketoacidosis.
Published in:
2022
By:
- Liu, Hongyan;
- Sridhar, Vikas S.;
- Perkins, Bruce A.;
- Rosenstock, Julio;
- Cherney, David Z. I.
Publication type:
journal article
Effects of ertugliflozin on uric acid and gout‐related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV.
Published in:
Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5336, doi. 10.1111/dom.15895
By:
- Sridhar, Vikas S.;
- Cosentino, Francesco;
- Dagogo‐Jack, Samuel;
- McGuire, Darren K.;
- Pratley, Richard E.;
- Cater, Nilo B.;
- Noyes Essex, Margaret;
- Mancuso, James P.;
- Zhao, Yujie;
- Cherney, David Z. I.
Publication type:
Article
Hypoglycaemia and kidney events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial.
Published in:
Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3478, doi. 10.1111/dom.15687
By:
- Odutayo, Ayodele;
- Cosentino, Francesco;
- Pratley, Richard E.;
- Dagogo‐Jack, Samuel;
- McGuire, Darren K.;
- Frederich, Robert;
- Fu, Wei;
- Cannon, Christopher P.;
- Cherney, David Z. I.
Publication type:
Article
An update review of post‐transplant diabetes mellitus: Concept, risk factors, clinical implications and management.
Published in:
Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2531, doi. 10.1111/dom.15575
By:
- Kanbay, Mehmet;
- Copur, Sidar;
- Topçu, A. Umur;
- Guldan, Mustafa;
- Ozbek, Lasin;
- Gaipov, Abduzhappar;
- Ferro, Charles;
- Cozzolino, Mario;
- Cherney, David Z. I.;
- Tuttle, Katherine R.
Publication type:
Article
Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease.
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3410, doi. 10.1111/dom.15203
By:
- Cherney, David Z. I.;
- Bhatt, Deepak L.;
- Szarek, Michael;
- Sun, Franklin;
- Girard, Manon;
- Davies, Michael J.;
- Pitt, Bertram;
- Steg, Ph. Gabriel
Publication type:
Article
Safety, tolerability, pharmacodynamics and pharmacokinetics of the soluble guanylyl cyclase activator BI 685509 in patients with diabetic kidney disease: A randomized trial.
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2218, doi. 10.1111/dom.15099
By:
- Cherney, David Z. I.;
- de Zeeuw, Dick;
- Heerspink, Hiddo J. L.;
- Cardona, Jose;
- Desch, Marc;
- Wenz, Arne;
- Schulze, Friedrich;
- Nangaku, Masaomi
Publication type:
Article
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease.
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1646, doi. 10.1111/dom.15019
By:
- Cherney, David Z. I.;
- Ferrannini, Ele;
- Umpierrez, Guillermo E.;
- Peters, Anne L.;
- Rosenstock, Julio;
- Powell, David R.;
- Davies, Michael J.;
- Banks, Phillip;
- Agarwal, Rajiv
Publication type:
Article
Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease.
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1398, doi. 10.1111/dom.14965
By:
- Kim, Joseph M.;
- Bhatt, Deepak L.;
- Dagogo‐Jack, Samuel;
- Cherney, David Z. I.;
- Cosentino, Francesco;
- McGuire, Darren K.;
- Pratley, Richard E.;
- Liu, Chih‐Chin;
- Cater, Nilo B.;
- Frederich, Robert;
- Mancuso, James P.;
- Cannon, Christopher P.
Publication type:
Article
Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus.
Published in:
Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1829, doi. 10.1111/dom.14769
By:
- Segar, Matthew W.;
- Kolkailah, Ahmed A.;
- Frederich, Robert;
- Pong, Annpey;
- Cannon, Christopher P.;
- Cosentino, Francesco;
- Dagogo‐Jack, Samuel;
- McGuire, Darren K.;
- Pratley, Richard E.;
- Liu, Chih‐Chin;
- Maldonado, Mario;
- Liu, Jie;
- Cater, Nilo B.;
- Pandey, Ambarish;
- Cherney, David Z. I.
Publication type:
Article
Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND.
Published in:
Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1578, doi. 10.1111/dom.14729
By:
- Sen, Taha;
- Scholtes, Rosalie;
- Greasley, Peter J.;
- Cherney, David Z. I.;
- Dekkers, Claire C. J.;
- Vervloet, Marc;
- Danser, Alexander H. J.;
- Barbour, Sean J.;
- Karlsson, Cecilia;
- Hammarstedt, Ann;
- Li, Qiang;
- Laverman, Gozewijn D.;
- Bjornstad, Petter;
- van Raalte, Daniel H.;
- Heerspink, Hiddo J. L.
Publication type:
Article
Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose‐lowering agent: An analysis from VERTIS CV.
Published in:
Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1245, doi. 10.1111/dom.14691
By:
- Dagogo‐Jack, Samuel;
- Cannon, Christopher P.;
- Cherney, David Z. I.;
- Cosentino, Francesco;
- Liu, Jie;
- Pong, Annpey;
- Gantz, Ira;
- Frederich, Robert;
- Mancuso, James P.;
- Pratley, Richard E.
Publication type:
Article
The differential effects of ertugliflozin on glucosuria and natriuresis biomarkers: Prespecified analyses from VERTIS CV.
Published in:
Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1114, doi. 10.1111/dom.14677
By:
- Cherney, David Z. I.;
- Cosentino, Francesco;
- Pratley, Richard E.;
- Dagogo‐Jack, Samuel;
- Frederich, Robert;
- Maldonado, Mario;
- Liu, Jie;
- Pong, Annpey;
- Liu, Chih‐Chin;
- Cannon, Christopher P.
Publication type:
Article
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and severe renal impairment.
Published in:
Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2632, doi. 10.1111/dom.14513
By:
- Cherney, David Z. I.;
- Ferrannini, Ele;
- Umpierrez, Guillermo E.;
- Peters, Anne L.;
- Rosenstock, Julio;
- Carroll, Amy K.;
- Lapuerta, Pablo;
- Banks, Phillip;
- Agarwal, Rajiv
Publication type:
Article
Changes in plasma and urine metabolites associated with empagliflozin in patients with type 1 diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2021, v. 23, n. 11, p. 2466, doi. 10.1111/dom.14489
By:
- Liu, Hongyan;
- Sridhar, Vikas S.;
- Montemayor, Daniel;
- Lovblom, Leif Erik;
- Lytvyn, Yuliya;
- Ye, Hongping;
- Kim, Jiwan;
- Ali, Mir Tariq;
- Scarr, Daniel;
- Lawler, Patrick R.;
- Perkins, Bruce A.;
- Sharma, Kumar;
- Cherney, David Z. I.
Publication type:
Article
Renal hyperfiltration defined by high estimated glomerular filtration rate: A risk factor for cardiovascular disease and mortality.
Published in:
Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2368, doi. 10.1111/dom.13831
By:
- Kanbay, Mehmet;
- Ertuglu, Lale A.;
- Afsar, Baris;
- Ozdogan, Elif;
- Kucuksumer, Zeynep S.;
- Ortiz, Alberto;
- Covic, Adrian;
- Kuwabara, Masanari;
- Cherney, David Z. I.;
- Raalte, Daniel H.;
- Zeeuw, Dick
Publication type:
Article
Association between uric acid, renal haemodynamics and arterial stiffness over the natural history of type 1 diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1388, doi. 10.1111/dom.13665
By:
- Lytvyn, Yuliya;
- Singh, Sunita K.;
- Lai, Vesta;
- Tse, Josephine;
- Cham, Leslie;
- Cherney, David Z. I.;
- Advani, Andrew;
- Sochett, Etienne;
- Bjornstad, Petter;
- Lovshin, Julie A.;
- Boulet, Genevieve;
- Farooqi, Mohammed A.;
- Weisman, Alanna;
- Perkins, Bruce A.;
- Lovblom, Leif E.;
- Keenan, Hillary A.;
- Brent, Michael H.;
- Paul, Narinder;
- Bril, Vera
Publication type:
Article
Sodium glucose cotransporter (SGLT)‐2 inhibitors: Do we need them for glucose‐lowering, for cardiorenal protection or both?
Published in:
Diabetes, Obesity & Metabolism, 2019, v. 21, p. 24, doi. 10.1111/dom.13692
By:
- Scholtes, Rosalie A.;
- Baar, Michaël J. B.;
- Lytvyn, Yuliya;
- Bjornstad, Petter;
- Nieuwdorp, Max;
- Cherney, David Z. I.;
- Raalte, Daniël H.
Publication type:
Article
The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 575, doi. 10.1111/dom.13556
By:
- Bjornstad, Petter;
- Singh, Sunita K.;
- Snell‐Bergeon, Janet K.;
- Lovshin, Julie A.;
- Lytvyn, Yuliya;
- Lovblom, Leif E.;
- Rewers, Marian J.;
- Boulet, Genevieve;
- Lai, Vesta;
- Tse, Josephine;
- Cham, Leslie;
- Orszag, Andrej;
- Weisman, Alanna;
- Keenan, Hillary A.;
- Brent, Michael H.;
- Paul, Narinder;
- Bril, Vera;
- Perkins, Bruce A.;
- Cherney, David Z. I.
Publication type:
Article
Cardiorenal Protection in Diabetic Kidney Disease.
Published in:
Endocrinology & Metabolism, 2021, v. 36, n. 2, p. 256, doi. 10.3803/EnM.2021.987
By:
- Lee, Jason F.;
- Berzan, Ecaterina;
- Sridhar, Vikas S.;
- Odutayo, Ayodele;
- Cherney, David Z. I.
Publication type:
Article
Evaluation of the Pharmacokinetics and Exposure–Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease.
Published in:
Clinical Pharmacokinetics, 2021, v. 60, n. 4, p. 517, doi. 10.1007/s40262-020-00956-1
By:
- van der Aart-van der Beek, Annemarie B.;
- Koomen, Jeroen V.;
- Dekkers, Claire C. J.;
- Barbour, Sean J.;
- Boulton, David W.;
- Gansevoort, Ron T.;
- Greasley, Peter J.;
- Abdul Gafor, Abdul Halim;
- Laverman, Gozewijn D.;
- Li, Qiang;
- Lim, Soo Kun;
- Stevens, Jasper;
- Vervloet, Marc G.;
- Singh, Sunita;
- Cattran, Daniel C.;
- Reich, Heather N.;
- Cherney, David Z. I.;
- Heerspink, Hiddo J. L.
Publication type:
Article
The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.
Published in:
Cardiovascular Diabetology, 2014, v. 13, n. 1, p. 2, doi. 10.1186/1475-2840-13-28
By:
- Cherney, David Z. I.;
- Perkins, Bruce A.;
- Soleymanlou, Nima;
- Har, Ronnie;
- Fagan, Nora;
- Johansen, Odd Erik;
- Woerle, Hans-Juergen;
- Eynatten, Maximilian von;
- Broedl, Uli C.
Publication type:
Article
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes.
Published in:
Diabetologia, 2024, v. 67, n. 1, p. 3, doi. 10.1007/s00125-023-06015-1
By:
- Sridhar, Vikas S.;
- Limonte, Christine P.;
- Groop, Per-Henrik;
- Heerspink, Hiddo J. L.;
- Pratley, Richard E.;
- Rossing, Peter;
- Skyler, Jay S.;
- Cherney, David Z. I.
Publication type:
Article
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial.
Published in:
Diabetologia, 2022, v. 65, n. 7, p. 1085, doi. 10.1007/s00125-022-05694-6
By:
- Waijer, Simke W.;
- Vart, Priya;
- Cherney, David Z. I.;
- Chertow, Glenn M.;
- Jongs, Niels;
- Langkilde, Anna Maria;
- Mann, Johannes F. E.;
- Mosenzon, Ofri;
- McMurray, John J. V.;
- Rossing, Peter;
- Correa-Rotter, Ricardo;
- Stefansson, Bergur V.;
- Toto, Robert D.;
- Wheeler, David C.;
- Heerspink, Hiddo J. L.
Publication type:
Article
Ertugliflozin, renoprotection and potential confounding by muscle wasting. Reply to Groothof D, Post A, Gans ROB et al [letter].
Published in:
2022
By:
- Cherney, David Z. I.;
- Charbonnel, Bernard;
- Cosentino, Francesco;
- Dagogo-Jack, Samuel;
- McGuire, Darren K.;
- Pratley, Richard;
- Shih, Weichung J.;
- Frederich, Robert;
- Maldonado, Mario;
- Pong, Annpey;
- Cannon, Christopher P.
Publication type:
Letter
Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial.
Published in:
Diabetologia, 2021, v. 64, n. 6, p. 1256, doi. 10.1007/s00125-021-05407-5
By:
- Cherney, David Z. I.;
- Charbonnel, Bernard;
- Cosentino, Francesco;
- Dagogo-Jack, Samuel;
- McGuire, Darren K.;
- Pratley, Richard;
- Shih, Weichung J.;
- Frederich, Robert;
- Maldonado, Mario;
- Pong, Annpey;
- Cannon, Christopher P.
Publication type:
Article
Discoveries from the study of longstanding type 1 diabetes.
Published in:
Diabetologia, 2021, v. 64, n. 6, p. 1189, doi. 10.1007/s00125-021-05403-9
By:
- Perkins, Bruce A.;
- Lovblom, Leif Erik;
- Lanctôt, Sebastien O.;
- Lamb, Krista;
- Cherney, David Z. I.
Publication type:
Article
Effects of ertugliflozin on renal function over 104 weeks of treatment: a post hoc analysis of two randomised controlled trials.
Published in:
Diabetologia, 2020, v. 63, n. 6, p. 1128, doi. 10.1007/s00125-020-05133-4
By:
- Cherney, David Z. I.;
- Heerspink, Hiddo J. L.;
- Frederich, Robert;
- Maldonado, Mario;
- Liu, Jie;
- Pong, Annpey;
- Xu, Zhi J.;
- Patel, Shrita;
- Hickman, Anne;
- Mancuso, James P.;
- Gantz, Ira;
- Terra, Steven G.
Publication type:
Article
Molecular regulation of the renin–angiotensin system by sodium–glucose cotransporter 2 inhibition in type 1 diabetes mellitus.
Published in:
Diabetologia, 2019, v. 62, n. 6, p. 1090, doi. 10.1007/s00125-019-4871-8
By:
- Kopecky, Chantal;
- Lytvyn, Yuliya;
- Domenig, Oliver;
- Antlanger, Marlies;
- Kovarik, Johannes J.;
- Kaltenecker, Christopher C.;
- Poglitsch, Marko;
- Perkins, Bruce A.;
- Rye, Kerry-Anne;
- Cherney, David Z. I.;
- Säemann, Marcus D.
Publication type:
Article
The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure.
Published in:
Diabetologia, 2018, v. 61, n. 10, p. 2098, doi. 10.1007/s00125-018-4669-0
By:
- Thomas, Merlin C.;
- Cherney, David Z. I.
Publication type:
Article
Improvements in peripheral vascular function with vitamin D treatment in deficient adolescents with type 1 diabetes.
Published in:
Pediatric Diabetes, 2018, v. 19, n. 3, p. 457, doi. 10.1111/pedi.12595
By:
- Deda, Livia;
- Yeshayahu, Yonatan;
- Sud, Shama;
- Cuerden, Meaghan;
- Cherney, David Z. I.;
- Sochett, Etienne B.;
- Mahmud, Farid H.
Publication type:
Article

Found: 86